These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31711927)

  • 1. Small molecule screening identifies inhibitors of the Epstein-Barr virus deubiquitinating enzyme, BPLF1.
    Atkins SL; Motaib S; Wiser LC; Hopcraft SE; Hardy PB; Shackelford J; Foote P; Wade AH; Damania B; Pagano JS; Pearce KH; Whitehurst CB
    Antiviral Res; 2020 Jan; 173():104649. PubMed ID: 31711927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1.
    Dyson OF; Pagano JS; Whitehurst CB
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Rad6/18 ubiquitin complex interacts with the Epstein-Barr virus deubiquitinating enzyme, BPLF1, and contributes to virus infectivity.
    Kumar R; Whitehurst CB; Pagano JS
    J Virol; 2014 Jun; 88(11):6411-22. PubMed ID: 24672041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.
    Whitehurst CB; Li G; Montgomery SA; Montgomery ND; Su L; Pagano JS
    mBio; 2015 Oct; 6(5):e01574-15. PubMed ID: 26489865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epstein-Barr virus (EBV) deubiquitinating enzyme BPLF1 reduces EBV ribonucleotide reductase activity.
    Whitehurst CB; Ning S; Bentz GL; Dufour F; Gershburg E; Shackelford J; Langelier Y; Pagano JS
    J Virol; 2009 May; 83(9):4345-53. PubMed ID: 19244336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus BPLF1 deubiquitinates PCNA and attenuates polymerase η recruitment to DNA damage sites.
    Whitehurst CB; Vaziri C; Shackelford J; Pagano JS
    J Virol; 2012 Aug; 86(15):8097-106. PubMed ID: 22623772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus deubiquitinating enzyme BPLF1 is involved in EBV carcinogenesis by affecting cellular genomic stability.
    Wu H; Han BW; Liu T; Zhang M; Wu Y; Nie J
    Neoplasia; 2024 Sep; 55():101012. PubMed ID: 38875930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Epstein-Barr virus deubiquitinase BPLF1 targets SQSTM1/p62 to inhibit selective autophagy.
    Ylä-Anttila P; Gupta S; Masucci MG
    Autophagy; 2021 Nov; 17(11):3461-3474. PubMed ID: 33509017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of cGAS- and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1.
    Lui WY; Bharti A; Wong NM; Jangra S; Botelho MG; Yuen KS; Jin DY
    PLoS Pathog; 2023 Feb; 19(2):e1011186. PubMed ID: 36802409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Epstein-Barr virus deubiquitinating enzyme BPLF1 regulates the activity of topoisomerase II during productive infection.
    Li J; Nagy N; Liu J; Gupta S; Frisan T; Hennig T; Cameron DP; Baranello L; Masucci MG
    PLoS Pathog; 2021 Sep; 17(9):e1009954. PubMed ID: 34543352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling.
    van Gent M; Braem SG; de Jong A; Delagic N; Peeters JG; Boer IG; Moynagh PN; Kremmer E; Wiertz EJ; Ovaa H; Griffin BD; Ressing ME
    PLoS Pathog; 2014 Feb; 10(2):e1003960. PubMed ID: 24586164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reading frame BPLF1 of Epstein-Barr virus: a homologue of herpes simplex virus protein VP16.
    Schmaus S; Wolf H; Schwarzmann F
    Virus Genes; 2004 Oct; 29(2):267-77. PubMed ID: 15284487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpesvirus deconjugases inhibit the IFN response by promoting TRIM25 autoubiquitination and functional inactivation of the RIG-I signalosome.
    Gupta S; Ylä-Anttila P; Callegari S; Tsai MH; Delecluse HJ; Masucci MG
    PLoS Pathog; 2018 Jan; 14(1):e1006852. PubMed ID: 29357390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of selective deubiquitinase inhibitors.
    Varca AC; Casalena D; Chan WC; Hu B; Magin RS; Roberts RM; Liu X; Zhu H; Seo HS; Dhe-Paganon S; Marto JA; Auld D; Buhrlage SJ
    Cell Chem Biol; 2021 Dec; 28(12):1758-1771.e13. PubMed ID: 34129829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OTUD1 enhances gastric cancer aggressiveness by deubiquitinating EBV-encoded protein BALF1 to stabilize the apoptosis inhibitor Bcl-2.
    Lin H; Han Y; Sang Y; Wu Y; Tian M; Chen X; Lin X; Lin X
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167132. PubMed ID: 38565386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Discovering Deubiquitinating Enzyme (DUB) Inhibitors.
    Schauer NJ; Magin RS; Liu X; Doherty LM; Buhrlage SJ
    J Med Chem; 2020 Mar; 63(6):2731-2750. PubMed ID: 31682427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14-3-3 scaffold proteins mediate the inactivation of trim25 and inhibition of the type I interferon response by herpesvirus deconjugases.
    Gupta S; Ylä-Anttila P; Sandalova T; Sun R; Achour A; Masucci MG
    PLoS Pathog; 2019 Nov; 15(11):e1008146. PubMed ID: 31710640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral deubiquitinating proteases and the promising strategies of their inhibition.
    van Vliet VJE; De Silva A; Mark BL; Kikkert M
    Virus Res; 2024 Jun; 344():199368. PubMed ID: 38588924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of Deubiquitinating Enzymes Block HIV-1 Replication and Augment the Presentation of Gag-Derived MHC-I Epitopes.
    Setz C; Friedrich M; Rauch P; Fraedrich K; Matthaei A; Traxdorf M; Schubert U
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28805676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epstein-Barr Virus Immunoevasins BCRF1 and BPLF1 Are Expressed by a Mechanism Independent of the Canonical Late Pre-initiation Complex.
    McKenzie J; Lopez-Giraldez F; Delecluse HJ; Walsh A; El-Guindy A
    PLoS Pathog; 2016 Nov; 12(11):e1006008. PubMed ID: 27855219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.